drugset / Trial / NCT02661061
Ketamine for Relapse Prevention in Recurrent Depressive Disorder
RandomizedParallel-groupQuadruple-blindOther
Summary
Randomised, controlled, parallel-group, pilot clinical trial of ketamine vs. midazolam for depression relapse prevention in persons at high risk. The main purpose of the pilot study is to assess trial processes to help inform a future definitive trial.
Timeline
- Start
- 2015-12
- Primary completion
- 2018-05-23
- Completion
- 2018-05-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.05 mg/kg | — |
| Comparator | Midazolam | Small molecule | 0.045 mg/kg | — |